ClinicalTrials.Veeva

Menu

The Role of Pro-angiogenic Immune Cells in Human Pregnancies

H

Hillel Yaffe Medical Center

Status

Unknown

Conditions

Fetal Growth Retardation
Preeclampsia

Treatments

Other: Biological specimen

Study type

Observational

Funder types

Other

Identifiers

NCT01177020
HYMC1069A

Details and patient eligibility

About

Identification of the presence of proangiogenic immune cells in normal human placentas may enable predication of some pregnancy disorders.

Enrollment

300 estimated patients

Sex

Female

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Placentas that have been delivered in the Medical Center

Exclusion criteria

  • None

Trial design

300 participants in 1 patient group

Placentas after delivery or abortion
Treatment:
Other: Biological specimen

Trial contacts and locations

1

Loading...

Central trial contact

Elad Mei-Dan, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems